Phibro Animal Health reported $232.52M in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Align Technology ALGN:US USD 890.35M 79.2M
Ani Pharmaceuticals ANIP:US USD 83.82M 9.97M
Aurora Cannabis Inc ACB:CN CAD 49.26M 952K
Bristol Myers Squibb BMY:US USD 11.22B 669M
Canopy Growth Corp WEED:CN CAD 117.86M 7.75M
Corcept Therapeutics CORT:US USD 101.73M 1.66M
Depomed DEPO:US USD 34.21M 919K
Eli Lilly And LLY:US USD 6.94B 453.6M
Endo International Ordinary Shares ENDP:US USD 541.69M 27.42M
Henry Schein HSIC:US USD 3.07B 37M
Idexx Laboratories IDXX:US USD 841.66M 18.88M
Knight Therapeutics Inc GUD:CN CAD 72.28M 3.54M
Lannett LCI:US USD 75.08M 890K
Merk MRK:US USD 14.96B 366M
Nektar Therapeutics NKTR:US USD 23.62M 2.04M
Pacira Pharmaceuticals PCRX:US USD 167.47M 1.94M
Patterson Companies PDCO:US USD 1.63B 102.94M
Phibro Animal Health PAHC:US USD 232.52M 22.74M
Prestige Brands PBH:US USD 289.27M 12.21M
Supernus Pharmaceuticals SUPN:US USD 177.35M 7.3M
Teva Pharmaceutical Industries TEVA:US USD 3.6B 191M
Zoetis ZTS:US USD 2B 50M